The peptide structure of Tirzepatide includes modifications that are believed to increase its stability and extend its activity, potentially leading to more sustained metabolic impacts.

Tirzepatide isn't the only weight-loss drug ... showed additional benefits for heart structure and function. However, patients weren't completely without side effects. Those in the treatment ...

Hines Jr Professor of Medicine at Yale University School of Medicine Tirzepatide decreases heart size to improve cardiac structure, function In a secondary analysis of the SUMMIT trial ...

STRIDES is a phase II trial evaluating the company's lead drug candidate Azelaprag in combination with Eli Lilly's weight management drug tirzepatide for obesity. The decision to discontinue the ...